908761918 | avmc | 45427009 | | 4087953 | 5/26/2007 12:00:00 am | gemella morbillorum bacteremia and possible endocarditis | | dis | admission date: 2/21/2007 report status:discharge date: 9/29/2007 final discharge orders dadamo , wilton t 981-00-02-7parkantservice: meddischarge patient on: 1/15/07 at 03:00 pmcontingent upon attending evaluationwill d/c order be used as the d/c summary: yesattending: rockwell , antione j. , m.d.code status:full codedisposition: rehabilitationmedications on admission:1. acetaminophen 650 mg po q6h2. acetylsalicylic acid 325 mg po qd3. albuterol nebulizer 2.5 mg neb q4h4. docusate sodium 100 mg po bid5. fluticasone nasal spray 2 spray na qd6. heparin 5000 units sc q8h7. insulin glargine 32 units sc qhs8. kcl slow release tab 40 meq po bid9. niferex 150 150 mg po bid10. pantoprazole 40 mg po q1211. sennosides 2 tab po bid12. simvastatin 40 mg po qhs13. albuterol nebulizer 2.5 mg neb q12h14. sarna unknown top unknown15. furosemide 80 mg po qam16. fluticasone propionate 110 mcg oral inhaler 2 puffs inh bid17. insulin lispro sliding scale sc18. losartan 50 mg po qd19. therapeutic multivitamins 1 tab po qd20. maalox extra strength unknown po unknown21. polyethylene glycol 17 gm po qd22. diphenhydramine 25 mg po unknown23. bisacodyl unknown po unknownmedications on discharge:miconazole nitrate 2% powder topical tp bidinstructions: apply to pannusacetylsalicylic acid 325 mg po dailyalbuterol nebulizer 2.5 mg neb q6h prn wheezingalbuterol nebulizer 2.5 mg neb q12hneomycin/poly b/bacitracin ointment ( bacitrac... )topical tp daily instructions: apply to right hand lesionalert overridden: override added on 3/10/07 by :potentially serious interaction: furosemide & neomycinsulfate , topical or ophth reason for override: awaredulcolax ( bisacodyl ) 5 mg po daily prn constipationceftriaxone 2 , 000 mg iv daily starting today ( 5/2 )instructions: to end 11/7/07colace ( docusate sodium ) 100 mg po bidfluticasone nasal spray 1 spray na bidflovent hfa ( fluticasone propionate inh )110 mcg inh bidlasix ( furosemide ) 80 mg po qam starting in am ( 7/26 )alert overridden: override added on 7/25/07 bymckeane , grover s. , m.d. , m.p.h.on order for lasix po ( ref # 515768930 )pt. has a possible allergy to sulfa; reaction is unknown.reason for override: no reaction previous alert overriddenoverride added on 7/25/07 by stines , toby f. , m.d. , m.p.h.potentially serious interaction: gentamicin sulfate &furosemide reason for override: awaregentamicin sulfate 80 mg iv daily starting today ( 5/2 )instructions: to continue at least for 2 weeks ( until11/27/07 )override notice: override added on 7/25/07 bywysocki , alan l. , m.d. , m.p.h.on order for lasix po ( ref # 515768930 )potentially serious interaction: gentamicin sulfate &furosemide reason for override: awareprevious override information:override added on 7/25/07 by nissila , chris j. , m.d. , m.p.h.on order for lasix inj iv ( ref # 782911242 )potentially serious interaction: gentamicin sulfate &furosemide , inj reason for override: awareheparin 5 , 000 units sc q8hinstructions: please give as instructed until pt out ofbed and ambulatory.lantus ( insulin glargine ) 36 units sc bedtimehold if: please give 1/2 dose if npolispro ( insulin lispro )sliding scale ( subcutaneous ) sc ac low scalecall ho if bs less than 60if bs is less than 125 , then do not administersupplemental ( sliding scale ) insulinif bs is 125-150 , then give 0 units subcutaneouslyif bs is 151-200 , then give 1 units subcutaneouslyif bs is 201-250 , then give 2 units subcutaneouslyif bs is 251-300 , then give 3 units subcutaneouslyif bs is 301-350 , then give 4 units subcutaneouslyif bs is 351-400 , then give 5 units subcutaneouslycall ho if bs is greater than 350if ordered qac administer at same time as , and in additionto ,standing insulin aspart order. if ordered hs administeralonek-dur ( kcl slow release tab ) 40 meq po bidas per smc potassium chloride policy:each 20 meq dose to be given with 4 oz of fluidniferex 150 150 mg po bidpantoprazole 40 mg po q12hmiralax ( polyethylene glycol ) 17 gm po dailyprn constipation number of doses required ( approximate ): 4sarna topical tp daily prn itchingsenna tablets ( sennosides ) 2 tab po bidsimvastatin 40 mg po bedtimefood/drug interaction instructionavoid grapefruit unless md instructs otherwise.override notice: override added on 11/18/07 bybang , eldon a. , m.d. , m.p.h.on order for multivitamin therapeutic po ( ref #138418200 )potentially serious interaction: simvastatin & niacin ,vit. b-3 reason for override: md awaremultivitamin therapeutic ( therapeutic multivi... )1 tab po dailyalert overridden: override added on 11/18/07 bykulesa , fausto j. , m.d. , m.p.h.potentially serious interaction: simvastatin & niacin ,vit. b-3 reason for override: md awarediet: fluid restrictiondiet: house / ada 1800 cals/dydiet: 2 gram sodiumactivity: walking as toleratedfollow up appointment( s ):dr. paris tribue 10/29/07 12:45pm scheduled ,dr. chadwick delvin ( infectious disease clinic ) 7/19/07 8am scheduled ,dr. jerrold elhadi , please call for follow up upon discharge from rehab ,allergy: sulfa , tetracyclineadmit diagnosis:bacteremiaprincipal discharge diagnosis ;responsible after study for causing admission )gemella morbillorum bacteremia and possible endocarditisother diagnosis;conditions , infections , complications , affecting treatment/staychf ( congestive heart failure ) dm ( diabetes mellitus ) cad ( coronaryartery disease ) af ( atrialfibrillation ) htn ( hypertension ) hypercholesterolemia ( elevatedcholesterol )operations and procedures:noneother treatments/procedures ( not in o.r. )tee 6/18/07brief resume of hospital course:cc: fever , +blood cx , r/o endocarditis--------hpi:82 year old man w/ pmh s/f avr for aortic stenosis ( august , 2007 ) ,htn , hyperlipidemia , cad s/p cabg , chf ( ef 60% 6/12 ) , atrialfibrillation w/ svr , iddm , fe def anemia and hemorrahgic stroke ( ~6months ago ) who was transferred from tanands hospital medical center due to fever ( 2days prior to presentation ) and positive ua and blood culturesignificant for gram positive cocci in clusters. concern thatpatient may have endocarditis. no other systemic signs orsymptoms.-------pmh: s/p avr ( 11/29 ) , htn , hyperlipidemia , cad w/ cabg x3 , a fib w/svr , iddm , anemia , s/p hemorrhagic stroke 9/21 , bph , s/p suprapubiccath placement--------home meds:albuterol , asa , sarna , colace ,fluticasone , lasix 80 qam , lispro ss , lantus 32u qhs , simvastatin ,tylenol prn , senna , losartan , mvi iron , kcl , protonix , maalox ,dulcolax , benadryl , miralax-------all: sulfa--swelling;tetracycline--swelling-------admit exam: vs: 98.5f , hr 49 , bp160/56 , sat99%ra gen-nad; heent-o/p clear , no icterius; neck-fupple ,no lan , fvp to ear; cv-brady irreg irreg , 4/8 sem at lusb;pulm-crackles at bases b/l; abd-benign; no stigmata of endocarditis;extr-1+ pitting edema to ankles b/l , 1+pulses b/l ,wwp-----admit labs: cr 1.9 ( baseline 1.3 ) , hct 31 ( baseline 29 ) , wbc8-------data:cxr: improved l pleural effusionekg: a fib@44 , lad , rbbb , old q's inf ( unchanged from prior )from rehab: 10/22 gpc in chains ( ?2/4 bottles )echo ( tte ) 1/8 ef 60-65% mild lvh with restrictive filling defect , mildlae/rae , aov peak grad 52mmhg , mean 2mmhg , peak aov velocity 3.6 m/s( elevated but stable )trace mr , trace tr , pap 31 +rap , no veg.u/a: 3+le , 7wbc , 1+bactucx: 10 , 000 colonies probable pseudomonas9/16 bcx: gemella morbillorum ( pansensitive ) , pcn mic 0.125( intermediate )wound cx of suprapubic cath insertion site: rare mrsa , few cns , rareenterococcitee: negative for ring abscess or valvular vegetation.-------a/p: 8 y/o m w/ mult med problems , s/p recent avr , transferred fromrehab w/ fever , +u/a , +blood cx's , with concern forendocarditis given recent avr. patient was started on ceftaz and vancoempirically , then was changed to ceftriaxone and gentamycin once gemellamorbillorum was identified on in-house blood cultures. patient remainedafebrile in-house and did not exhibit any significant leukocytosis , orstigmata of endocardititis. surveillance cultures drawn after startingantibiotics have remained negative to date.--------1. cardiovascular ischemia: no cp/ct/cd. hx of cad s/p cabg continuew/ aspirin 325mg po qd rhythm: pt w hx of af w/ svr. patient placedon telemetry for observation. is bradycardic atbaseline , asymptomatic has refused ppm in the past per report. some runsnsvt up to 14 beats , checking bid lytes keep mg>2 and k.4 , no nodalagents given bradycardia. pump: hx chf documented , last ef 60%. ptappears fluid up , responded well to 60 iv lasix x1. pt then appearedeuvolemic and lasix was held , for sev days and became hypervolemic ,lasix 60mg iv repeated and patient restarted on home lasix dose ( 80mgqam ). patient's discharge weight is 96.7kg. his dry weight isapproximately 93kg. discharge weight is 96.7kg. his in/out goal is 500ccneg daily. -tte neg for veg , but given high risk , tee obtained on 7/4to assess for possible endocarditis. was negative for ring abscess orvalvular vegetationn. pt will still require treatement forendocarditis as cannot be entirely ruled out. held losartandue to acute worsening of renal function as well as initiation ofgentamycin. pt can resume use once gent is discontinued.2. renal: cr slightly elevated abovebaseline ( 1.1-1.3 ) on admit , likely 2/2 chf and poor forward flow hasdeclined to near baseline and was 1.4 at time of d/c.3. gu: pt has hx of bph and has a suprapubic cathether that was insertedat the time of surgery due to difficulty to pass foley. at brmc pt hasbeen clamped repeatedly over the last week w/ pvr checked. ptwithout difficulty in house w/ pvr of 50cc. urology consulted andsuprapubic catheter pulled without difficulty. cont dry sterile dressingdaily to wound.3. id-gemella morbillorum in blood , pseudomonas in urine althoughonly 10k colonies. pt treated with 5 days of ceftaz , and 4 daysvanc. decision was made to d/c ceftaz given only 10k coloniespseudomonas in urine and some coverage with ceftriaxone and gent ( started10/8 ) d/c'd vanc 10/24 will need 6 wks ctx and at least 2 wks gent forpresumed endocarditis. picc placed 10/84. gi -continue protonix 40 q12 all stools guaiac negative in house.5. endocrine -hx of iddm will titrate up insulin to 36u qhsw/ insluin aspart ss6. fen -cardiac diet -cont mvi -bid lytes w/ goal to keep k/mg march7. gi -continue senna and colace8. pulm -cont flovent 2 puffs bid and albuterol q12h9. heme: cont niferex bid for iron deficiency anemia.pt also with mildeosinophilia on diff , should be monitored.10. derm: skin tear on right hand , placing neomycin ointment and steriledry dressing daily.prophylaxis-cont heparin 5000 tid -cont protonix 40q12hfull codeadditional comments: you were admitted to the hospital with a bacterial blood infection andpossible heart valve infection. you were treated with intravenousantibiotics and improved.plan:1. continue ceftriaxone for 6 weeks to end 11/7/07 and gentamycin tocontinue for at least 2 weeks ( at least until 11/27/07 )2. please go to your follow up appointment with dr. ervin micalizzi in theinfectious disease clinic at the miltintergulf health services on 7/19/07 at 8am.3. please go to your follow up appointment with dr. lickert on 10/29/07 at12:45pm.4. please call dr. harvey ogata office for follow up upon discharge from rehab.5. please stop taking your home losartan medicine while you are onantibiotics. dr. dowsett can decide when to restart this medicine.6. after leaving rehab , if you are still on antibiotics , please have yourblood drawn twice a week. your results will be sent to dr. ribas7. if you have fever , sweats chills , rash , worsening shortness of breath ,or chest pain please contact your physician or return to the er.8. continue all other home meds.9. continue low salt , low fat , low cholesterol diet , continue to restrictall fluids to 2 liters daily.discharge condition: stableto do/plan:1. please check basic metabolic panel twice daily while activelydiuresing on lasix. then check basic metabilic panel twice weekly to be tofollow lytes and creatinine while on antibiotics.2. please draw cbc with differential once weekly while on gent andceftriaxone.3. please draw gent trough once weekly and adjust gent dose as needed.4. infectious disease consultant to determine whether gentamicin should becontinued beyond 2 weeks5. consider surveillance blood cultures 1 week after completingantibiotic therapy to document clearance.6. please place neomycin ointment to right hand lesion daily and cover withdry sterile dressing once daily.7. cont dry sterile dressing to suprpubic cath site daily until healed.8. consider repeat urine cultures 2 weeks after d/c to document clearanceof pseudomonas.9. consider restarting losartan after gentamicin is discontinued givenunderlying renal insufficiency.10. please follow up pending blood cultures ( no growth to date at time ofdischarge. )11. please do daily weights on patient.no dictated summaryentered by: okihara , whitney m. , m.d. , m.p.h. ( cq197 ) 8/1/07 @ 11 end of discharge orders